Literature DB >> 179150

Studies on the inhibitory activities of human serum lipoproteins for Japanese encephalitis virus.

K F Shortridge, W K Ho, A Oya, M Kobayashi.   

Abstract

Human serum lipoproteins were purified by ultracentrifuging and their concentrations adjusted as required to be within the normal male/female serum range for all assays. The activities in inhibition of hemagglutination (HAI) for Japanese encephalitis virus were--low density lipoprotein (LDL) greater than very low density lipoprotein (VLDL) greater than high density lipoprotein (HDL). Heating (56 degrees C/30 minutes) caused the LDL titer to fall and freeze-thawing (20 degrees C/room temperature) the VLDL titer to rise slightly, possibly as a result of alteration in lipoprotein structure. The additon of lipoprotein depleted serum appeared to dampen these effects and there was no nett change in titer when it was added to a lipoprotein mixture. Similarly, unfractionated normal serum showed no significant change in titer after these treatments. The lipoproteins lacked significant virus neutralizing (VN) activity and this remained so in spite of fluctuations in HAI titer after heating and freeze-thawing.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 179150

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  4 in total

1.  Role for monokines in the metabolic effects of endotoxin. Interferon-gamma restores responsiveness of C3H/HeJ mice in vivo.

Authors:  S Adi; A S Pollock; J K Shigenaga; A H Moser; K R Feingold; C Grunfeld
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

2.  Endotoxin and cytokines increase hepatic messenger RNA levels and serum concentrations of apolipoprotein J (clusterin) in Syrian hamsters.

Authors:  I Hardardóttir; S T Kunitake; A H Moser; W T Doerrler; J H Rapp; C Grünfeld; K R Feingold
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

3.  Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death.

Authors:  H W Harris; C Grunfeld; K R Feingold; T E Read; J P Kane; A L Jones; E B Eichbaum; G F Bland; J H Rapp
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

4.  Role for circulating lipoproteins in protection from endotoxin toxicity.

Authors:  K R Feingold; J L Funk; A H Moser; J K Shigenaga; J H Rapp; C Grunfeld
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.